Jareeporn Jarukornsakul, Group CEO of WHA Corporation, presented a perspective on the transformative potential of DNA sequencing and genomic medicine. She emphasized its role in revolutionizing healthcare, biological development, and the overall economy of Thailand.

This technology is crucial for advancing precision medicine in Thailand, enabling personalized treatments, accurate disease risk assessment, and the development of a comprehensive Thai genome database, ultimately driving economic growth and innovation beyond traditional sectors.